MACHAVERT PHARMACEUTICALS
Machavert is creating novel drug substances that will embrace the unique proprieties of nature inspired lipids. Their drug platform offers wide range of drug candidates for oncology treatments.
MACHAVERT PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Denver, Colorado, United States
Country:
United States
Website Url:
http://www.machavert.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Auron Healthcare
Auron Healthcare is a pharmaceutical company developing innovative pharmaceuticals.
BiPar Sciences
BiPar Sciences is a pharmacological company developing PARP inhibitors as cancer therapies.
Orano Med
Orano Med develops targeted therapies against cancers.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Taiho Oncology
Taiho Oncology is a pharmaceutical company that specializes in developing innovative cancer treatments.
Current Employees Featured
Founder
Official Site Inspections
http://www.machavert.com Semrush global rank: 5.27 M Semrush visits lastest month: 1.56 K
- Host name: mangoweb-lb.vshosting.cz
- IP address: 185.59.211.200
- Location: Czechia
- Latitude: 50.0848
- Longitude: 14.4112
- Timezone: Europe/Prague
More informations about "Machavert Pharmaceuticals"
Machavert - Revolution in Healing
Machavert is a pharmaceutical company that develops first-in-class targeted therapeutics to treat cancer. Our approach takes advantage of proprietary RAL GTPase inhibitors to control KRAS mutant cancer growth and metastasis.See details»
News all - Machavert
Feb 13, 2019 · A competitive salary, health, dental, vision, 401k, and stock options plan and the opportunity to grow with our ambitious project to become a new global drug discovery …See details»
Dr. Neal Goodwin joins Machavert as Chief Science Officer
Feb 1, 2018 · Neal is going to tremendously strengthen Machavert’s expertise in preclinical research and cancer biology and help the company reach new heights in terms of tackling …See details»
Machavert Pharmaceuticals - Crunchbase Company Profile
Machavert is creating novel drug substances that will embrace the unique proprieties of nature inspired lipids. Their drug platform offers wide range of drug candidates for oncology …See details»
Machavert Pharmaceuticals - LinkedIn
Machavert develops first-in-class precision medicine therapeutics to inhibit KRAS mutant cancer growth and metastasis. FOUNDER: Božà - retreat centrum, VIVANTIS, Celostnimedicina.cz STARTUP...See details»
Jakub Staszak-Jirkovsky - Founder & CEO at Machavert ... - The Org
Jakub Staszak-Jirkovsky is the CEO & Founder of Machavert Pharmaceuticals. Previously, Jakub worked as a Postdoctoral Apointee at Argonne National Laboratory, focusing on enhancing …See details»
Machavert Pharmaceuticals, RAL GTPase Inhibitors, …
Machavert has received an exclusive license to the RAL inhibitor portfolio from the University of Colorado. In cancer, RAL reacts to mutant KRAS by transmitting multiple signals that result in increased tumor cell growth and tumor metastasis.See details»
Machavert Pharmaceuticals - Contacts, Employees, Board …
Machavert is a pharmaceutical company developing innovative treatments against cancerSee details»
Machavert Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Machavert Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug …
Nov 26, 2018 · Machavert Pharmaceuticals is a preclinical stage drug development company focused on advanced therapies based on its proprietary bioactive phospholipid platform for the …See details»
Machavert Pharmaceuticals - VentureRadar
Website: https://www.machavert.com/ Develops novel small molecule RAL GTPase inhibitors targeting KRAS mutant cancer growth and metastasis, focusing on precision medicine …See details»
Machavert - Products, Competitors, Financials, Employees, …
Machavert is a pharmaceutical company focused on the development of precision cancer therapeutics in the healthcare sector. The company's main offerings include innovative …See details»
Machavert Pharmaceuticals Company Profile - Office Locations
Machavert is a company targeting cancer and autoimmune diseases. It specializes in precision medicine, autoimmunity and immuno-oncology, and targeted drug delivery.See details»
CEOCFO Magazine interview with Machavert Pharmaceuticals CEO …
Feb 18, 2020 · Machavert Pharmaceuticals is a preclinical stage drug development company focused on precision medicine based on small molecule RAL GTPase inhibitors against KRAS …See details»
CEOCFO Magazine interview with Machavert Pharmaceuticals CEO …
Feb 17, 2020 · Machavert Pharmaceuticals is a preclinical stage drug development company focused on precision medicine based on small molecule RAL GTPase inhibitors against KRAS …See details»
The Scientific Advisory Board meeting pinpoints R&D ... - Machavert
Feb 19, 2020 · Machavert CSO, Dr. Neal Goodwin, and members of our R&D team have presented research results to the SAB. The meeting has sparked many fruitful discussions and …See details»
Machavert - Overview, News & Similar companies | ZoomInfo.com
Aug 27, 2019 · View Machavert (www.machavert.com) location in Colorado, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Research programme: anti-cancer and autoimmune disorder …
Machavert Pharmaceuticals is developing a series of immuno-oncology therapeutics using its proprietary phospholipid platform for tumour-specific drug delivery, Research programme: anti …See details»
Machavert closes a first tranche of A Round financing of $2.2M
This round of financing follows the seed stage funded with $1M in which Machavert established a wet-chemistry synthetic lab to produce intellectual property that saw compelling biology results …See details»
Research programme: anticancer therapeutics - Machavert …
Mar 28, 2022 · Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.See details»